467 related articles for article (PubMed ID: 15123680)
1. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
2. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E.
Fu T; Kashireddy P; Borensztajn J
Biochem J; 2003 Aug; 373(Pt 3):941-7. PubMed ID: 12713444
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice.
Fu T; Kozarsky KF; Borensztajn J
J Biol Chem; 2003 Dec; 278(52):52559-63. PubMed ID: 14570884
[TBL] [Abstract][Full Text] [Related]
4. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
5. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins.
Lindén D; Alsterholm M; Wennbo H; Oscarsson J
J Lipid Res; 2001 Nov; 42(11):1831-40. PubMed ID: 11714852
[TBL] [Abstract][Full Text] [Related]
6. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
[TBL] [Abstract][Full Text] [Related]
7. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
9. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
10. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
11. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
12. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol.
Sorci-Thomas M; Wilson MD; Johnson FL; Williams DL; Rudel LL
J Biol Chem; 1989 May; 264(15):9039-45. PubMed ID: 2722816
[TBL] [Abstract][Full Text] [Related]
13. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
Lindén D; Lindberg K; Oscarsson J; Claesson C; Asp L; Li L; Gustafsson M; Borén J; Olofsson SO
J Biol Chem; 2002 Jun; 277(25):23044-53. PubMed ID: 11925428
[TBL] [Abstract][Full Text] [Related]
14. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
Anber V; Millar JS; McConnell M; Shepherd J; Packard CJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
Rapp JH; Lespine A; Hamilton RL; Colyvas N; Chaumeton AH; Tweedie-Hardman J; Kotite L; Kunitake ST; Havel RJ; Kane JP
Arterioscler Thromb; 1994 Nov; 14(11):1767-74. PubMed ID: 7947602
[TBL] [Abstract][Full Text] [Related]
16. Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms.
Srivastava RA; Averna M; Srivastava N; Pape ME
Int J Biochem Cell Biol; 2001 Dec; 33(12):1215-26. PubMed ID: 11606258
[TBL] [Abstract][Full Text] [Related]
17. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
[TBL] [Abstract][Full Text] [Related]
18. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.
Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW
J Lipid Res; 2001 Feb; 42(2):201-10. PubMed ID: 11181749
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
[TBL] [Abstract][Full Text] [Related]
20. Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins.
Kushwaha RS; McMahan CA; Mott GE; Carey KD; Reardon CA; Getz GS; McGill HC
J Lipid Res; 1991 Dec; 32(12):1929-40. PubMed ID: 1687745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]